Detail (Long)
<b>American Indian and Alaska Native children 8-19 mo:</b> Continue offering nirsevimab to those not eligible for palivizumab who live in remote regions or in communities w/ high rates of severe RSV among older infants and toddlers.<sup>1</sup>